Safety and Efficacy Study of TQ-B3101 in Patients With ROS1-positive Non-Small Cell Lung Cancer (NSCLC)
Clinical trial NCT03972189 · UNKNOWN
Trial details
- NCT number
- NCT03972189
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-24
- Primary completion
- 2021-03-01
- Enrollment
- 111
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.